Soleno Therapeutics Inc. (NASDAQ:SLNO) is one of the cheap US stocks to buy according to analysts. On November 18, Wolfe Research analyst Kalpit Patel initiated coverage of Soleno Therapeutics with an Outperform rating and $75 price target. The company’s shares showed recent weakness in the market due to a sequential slowing in the number of new patient starts. However, Patel noted that the market’s safety concerns surrounding this slowdown are considered overblown. Based on the firm’s proprietary survey ...